Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors

Urological Research

Volumn 30, Issue 6, 2003, Pages 387-389

  Visapää, Harri ^a   Seligson, David ^a   Huang, Yunda ^a   Rao, Jian Yu ^a   Belldegrun, Arie ^a   Horvath, Steve ^a   Palotie, Aarno ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gelsolin; Ki67; PTEN; Renal cell carcinoma; Tissue microarray analysis

Indexed keywords

BIOLOGICAL MARKER; GELSOLIN; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY SARCOMA; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037294547     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0284-z     Document Type: Article

References (22)

1. Delahunt B (1999) Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology 31: 18
2. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655
3. Kanamaru H, Li B, Miwa Y, Akino H, Okada K (1999) Immunohistochemical expression of p53 and bcl-2 proteins is not associated with sarcomatoid change in renal cell carcinoma. Urol Res 27: 169
4. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844
5. Kuroiwa K, Konomoto T, Kumazawa J, Naito S, Tsuneyoshi M (2001) Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma. J Surg Oncol 77: 123
6. Kwiatkowski DJ (1999) Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol 11: 103
7. Lee H-K, Driscoll D, Asch H, Asch B, Zhang PJ (1999) Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Prostate 40: 14
8. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943
9. Lueck A, Brown D, Kwiatkowski DJ (1998) The actin-binding proteins adseverin and gelsolin are both highly expressed but differentially localized in kidney and intestine. J Cell Sci 111: 3633
10. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. Cancer 89: 604
11. Pantuck AJ, Zisman A, Belldegrun A (2001) Biology of renal cell carcinoma: changing concepts in classification and staging. Semin Urol Oncol 19 (2): 72
12. Rao JY, Seligson D, Visapää H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A (2002) Tissue microarray analysis (TMA) of cytoskeletal actin associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95: 1247
13. Renshaw AA, Loughlin KR, Dutta A (1998) Cyclin A and MIB1 (KI67) as markers of proliferative activity in primary renal neoplasms. Mod Pathol 11: 963
14. Shieh D-B, Godleski J, Herndon JE, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ (1999) Cell motility as a prognostic factor in stage I nonsmall cell lung carcinoma. Cancer 85: 47
15. Sobin LH, Wittekind C (1997) TNM classification of malignant tumors, 5th edition. John Wiley and Sons, New York
16. Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N (1995) Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res 55: 3228
17. Thor AD, Edgerton SM, Liu S, Moore DHI, Kwiatkowski DJ (2001) Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res 7: 2415
18. Tickoo SK, Amin MB, Linden MD, Zarbo RJ (1998) The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential. Mod Pathol 11: 1115
19. Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB (2001) Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat 65: 11
20. Yamada KM, Araki M (2001) Tumor suppressor PTEN: modulator of cell signaling, growth migration and apoptosis. J Cell Sci 114: 2375
21. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM (1999) Histopathology and molecular genetics of renal tumors: toward unification of a classification system. J Urol 162: 1246
22. Zhou M, Rubin MA (2001) Molecular markers for renal cell carcinoma: impact on diagnosis and treatment. Semin Urol Oncol 19 (2): 80